✦ LIBER ✦

Retrospective assessment of the potential impacts bone marrow product quality has on utilization of bone marrow as a cell source for transplant

✍ Scribed by Prokopishyn, N.L.

Book ID: 122566333
Publisher: Informa plc
Year: 2013
Tongue: English
Weight: 173 KB
Volume: 15
Category: Article
ISSN: 1465-3249
DOI: 10.1016/j.jcyt.2013.01.095

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of a single human leucocyte antig

Impact of a single human leucocyte antigen (HLA) allele mismatch on the outcome of unrelated bone marrow transplantation over two time periods. A retrospective analysis of 3003 patients from the HLA Working Group of the Japan Society for Blood and Marrow

✍ Kanda, Yoshinobu; Kanda, Junya; Atsuta, Yoshiko; Maeda, Yoshinobu; Ichinohe, Tat 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 492 KB

Eradication of Minimal Residual Disease

Eradication of Minimal Residual Disease with Alemtuzumab in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients: The Need for a Standard Method of Detection and the Potential Impact of Bone Marrow Clearance on Disease Outcome

✍ Montillo, Marco; Schinkoethe, Timo; Elter, Thomas 📂 Article 📅 2005 🏛 Informa plc 🌐 English ⚖ 133 KB

Expression of CD134 (0X-40) on T cells d

Expression of CD134 (0X-40) on T cells during the first 100 days following allogeneic bone marrow transplantation as a marker for lymphocyte activation and therapy-resistant graft-versus-host disease

✍ L.S. Lamb Jr; S.A. Abhyankar; L. Hazlett; W. O'Neal; R.S. Folk; S. Vogt; R.S. Pa 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB 👁 1 views

## CD134 (OX-40 ) is an activation-associated antigen which functions as a costimulatory receptor for CD4؉ T cells. In order to determine the expression of CD134 during immune recovery following allogeneic bone marrow transplantation (BMT), we measured its expression on T cells and T cell subsets